小知识:ICU常用抢救药物用法总结

2014-05-20 佚名 佚名

各种急救药品五花八门,药效更是随着用药剂量而随时改变,新上任的医生们总是计算得脸红脖子粗,好讨厌~~~今天小编给大家整理了一些急救常用药物的常用剂量和配置方法,希望能对大家有所帮助~~ 多巴胺(多巴酚丁胺)  20mg/2ml 用量:1~20ug/kg/min;升压作用从5ug/kg/min开始。 极量:20ug/kg/min 配制:W*3 + NS至50ml 50kg:150mg+NS

各种急救药品五花八门,药效更是随着用药剂量而随时改变,新上任的医生们总是计算得脸红脖子粗,好讨厌~~~今天小编给大家整理了一些急救常用药物的常用剂量和配置方法,希望能对大家有所帮助~~

多巴胺(多巴酚丁胺)  20mg/2ml
用量:1~20ug/kg/min;升压作用从5ug/kg/min开始。
极量:20ug/kg/min
配制:W*3 + NS至50ml
50kg:150mg+NS35ml—1ml/h=1ug/kg/min
60kg:180mg+NS32ml—1ml/h=1ug/kg/min
70kg:210mg+NS29ml—1ml/h=1ug/kg/min

肾上腺素  1 mg/ml
用量:从1ug/min 开始调
配制:肾上腺素1mg+溶液250ml
15ml/h=1ug/min

异丙肾上腺素  1mg/2ml
用量:0.05~0.3ug/kg/min
配制:异丙1mg+5%GS250ml
50kg:38ml/h=0.05ug/kg/min
60kg:45ml/h=0.05ug/kg/min
70kg:53ml/h=0.05ug/kg/min

去甲肾上腺素 2 mg/1ml
(Kg×0.3)mg加NS至50ml/ iv 泵入,1ml/h 相当于0.1ug/Kg/min如:体重60Kg的患者,用量为:0.5ug/Kg/min
18mg+NS 41 ml / iv 泵入,5ml/h
常用剂量为0.1-2.0ug/kg/min
报告最大剂量可达10.0mcg/kg/min

间羟胺 

主要激动α受体,升压效果比去甲肾上腺素稍弱,但较持久,有中等度加强心脏收缩的作用

硝普钠 

50mg/支 高血压急症、急性心肌梗塞或瓣膜(二尖瓣或主动脉瓣)关闭不全时的急性心力衰竭
用量:1~3ug/kg/min,从0.5ug/kg/min调
极量:8ug/kg/min
配制:
50kg:0.3ml/h=0.1ug/kg/min
60kg:0.4ml/h=0.1ug/kg/min
70kg:0.4ml/h=0.1ug/kg/min
50 mg+5%GS 50ml/iv泵入0.6ml/h(10ug/min起始),
可用到200-300ug/min
3ml/h=5ug/min

鲁南欣康(单硝酸异山梨醇酯)
用量:5~30ug/min,每5ug 开始调
配制:鲁南欣康40mg+溶液250ml
15ml/h=1mg/min

可达龙(胺碘酮)
首用:NS20ml+可达龙75mg,20 分钟慢推完
用量:0.3~0.5mg/min
配制:
可达龙225mg+溶液250ml
20ml/h=0.3mg/min
可达龙300mg+溶液250ml
15ml/h=0.3mg/min

心律平(普罗帕酮)
首用:NS20ml+心律平70mg 10 分钟慢推完
用量:0.3mg/min
配制:心律平210mg+溶液250ml
21ml/h=0.3mg/min

米力农
首用:NS20ml+米力农2.5mg 10分钟慢推完
用量:0.35mg/kg/d
极量:1.13mg/kg/d
配制:米力农 7.5mg+溶液250ml
50kg:35ml/h=0.35ug/kg/min
60kg:42ml/h=0.35ug/kg/min
70kg:49ml/h=0.35ug/kg/min

阿托品
用量:1~4ug/min

乌拉地尔(利喜定/压宁定)α受体阻滞剂  25mg/5ml/支
用量:0.1~2mg/min 从0.1mg 开始
配制:
100mg+5%GS250ml
15ml/h=0.1mg/min
先缓慢静注10-50mg,监测血压变化。效果在5分钟内显示后维持降压效果:100mg稀释成50ml(NS,5-10%GS,5%果糖均可)最大药物浓度为4mg/ml
初始输入速度为2mg/min,维持给药9mg/h
若将250mg乌拉地尔溶解在500ml液体里则1mg乌拉地尔相当于44滴或2.2ml输入液

硝酸甘油
用量:5~30ug/min,每5ug 开始调
配制:NG25mg+5%GS 250ml
配制:阿托品1mg+5%GS 250ml

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (21)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=176498, encodeId=61fb1e6498b0, content=继续努力,写的很好,如果结合案例病情对年轻医生更有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/fFgUJknhibCy1mxLxGwk0ndVfWXmBh8AOibSFDqsSgnoeicu2QjNDYn0g/0, createdBy=c24f1943525, createdName=覃医生, createdTime=Thu Feb 16 18:21:30 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82144, encodeId=f1fc821445e, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82161, encodeId=36408216109, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82160, encodeId=c53c821604d, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82159, encodeId=e6798215914, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82158, encodeId=306b8215817, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82157, encodeId=113a8215efa, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82156, encodeId=d32d8215668, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82155, encodeId=192282155c5, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82154, encodeId=f979821548c, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=)]
    2017-02-16 覃医生

    继续努力,写的很好,如果结合案例病情对年轻医生更有帮助

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=176498, encodeId=61fb1e6498b0, content=继续努力,写的很好,如果结合案例病情对年轻医生更有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/fFgUJknhibCy1mxLxGwk0ndVfWXmBh8AOibSFDqsSgnoeicu2QjNDYn0g/0, createdBy=c24f1943525, createdName=覃医生, createdTime=Thu Feb 16 18:21:30 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82144, encodeId=f1fc821445e, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82161, encodeId=36408216109, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82160, encodeId=c53c821604d, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82159, encodeId=e6798215914, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82158, encodeId=306b8215817, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82157, encodeId=113a8215efa, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82156, encodeId=d32d8215668, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82155, encodeId=192282155c5, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82154, encodeId=f979821548c, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=)]
    2016-04-24 忠诚向上

    继续努力

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=176498, encodeId=61fb1e6498b0, content=继续努力,写的很好,如果结合案例病情对年轻医生更有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/fFgUJknhibCy1mxLxGwk0ndVfWXmBh8AOibSFDqsSgnoeicu2QjNDYn0g/0, createdBy=c24f1943525, createdName=覃医生, createdTime=Thu Feb 16 18:21:30 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82144, encodeId=f1fc821445e, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82161, encodeId=36408216109, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82160, encodeId=c53c821604d, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82159, encodeId=e6798215914, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82158, encodeId=306b8215817, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82157, encodeId=113a8215efa, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82156, encodeId=d32d8215668, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82155, encodeId=192282155c5, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82154, encodeId=f979821548c, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=)]
    2016-04-24 忠诚向上

    继续努力

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=176498, encodeId=61fb1e6498b0, content=继续努力,写的很好,如果结合案例病情对年轻医生更有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/fFgUJknhibCy1mxLxGwk0ndVfWXmBh8AOibSFDqsSgnoeicu2QjNDYn0g/0, createdBy=c24f1943525, createdName=覃医生, createdTime=Thu Feb 16 18:21:30 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82144, encodeId=f1fc821445e, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82161, encodeId=36408216109, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82160, encodeId=c53c821604d, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82159, encodeId=e6798215914, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82158, encodeId=306b8215817, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82157, encodeId=113a8215efa, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82156, encodeId=d32d8215668, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82155, encodeId=192282155c5, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82154, encodeId=f979821548c, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=)]
    2016-04-24 忠诚向上

    继续努力

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=176498, encodeId=61fb1e6498b0, content=继续努力,写的很好,如果结合案例病情对年轻医生更有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/fFgUJknhibCy1mxLxGwk0ndVfWXmBh8AOibSFDqsSgnoeicu2QjNDYn0g/0, createdBy=c24f1943525, createdName=覃医生, createdTime=Thu Feb 16 18:21:30 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82144, encodeId=f1fc821445e, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82161, encodeId=36408216109, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82160, encodeId=c53c821604d, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82159, encodeId=e6798215914, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82158, encodeId=306b8215817, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82157, encodeId=113a8215efa, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82156, encodeId=d32d8215668, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82155, encodeId=192282155c5, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82154, encodeId=f979821548c, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=)]
    2016-04-24 忠诚向上

    继续努力

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=176498, encodeId=61fb1e6498b0, content=继续努力,写的很好,如果结合案例病情对年轻医生更有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/fFgUJknhibCy1mxLxGwk0ndVfWXmBh8AOibSFDqsSgnoeicu2QjNDYn0g/0, createdBy=c24f1943525, createdName=覃医生, createdTime=Thu Feb 16 18:21:30 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82144, encodeId=f1fc821445e, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82161, encodeId=36408216109, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82160, encodeId=c53c821604d, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82159, encodeId=e6798215914, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82158, encodeId=306b8215817, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82157, encodeId=113a8215efa, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82156, encodeId=d32d8215668, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82155, encodeId=192282155c5, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82154, encodeId=f979821548c, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=)]
    2016-04-24 忠诚向上

    继续努力

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=176498, encodeId=61fb1e6498b0, content=继续努力,写的很好,如果结合案例病情对年轻医生更有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/fFgUJknhibCy1mxLxGwk0ndVfWXmBh8AOibSFDqsSgnoeicu2QjNDYn0g/0, createdBy=c24f1943525, createdName=覃医生, createdTime=Thu Feb 16 18:21:30 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82144, encodeId=f1fc821445e, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82161, encodeId=36408216109, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82160, encodeId=c53c821604d, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82159, encodeId=e6798215914, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82158, encodeId=306b8215817, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82157, encodeId=113a8215efa, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82156, encodeId=d32d8215668, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82155, encodeId=192282155c5, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82154, encodeId=f979821548c, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=)]
    2016-04-24 忠诚向上

    继续努力

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=176498, encodeId=61fb1e6498b0, content=继续努力,写的很好,如果结合案例病情对年轻医生更有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/fFgUJknhibCy1mxLxGwk0ndVfWXmBh8AOibSFDqsSgnoeicu2QjNDYn0g/0, createdBy=c24f1943525, createdName=覃医生, createdTime=Thu Feb 16 18:21:30 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82144, encodeId=f1fc821445e, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82161, encodeId=36408216109, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82160, encodeId=c53c821604d, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82159, encodeId=e6798215914, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82158, encodeId=306b8215817, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82157, encodeId=113a8215efa, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82156, encodeId=d32d8215668, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82155, encodeId=192282155c5, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82154, encodeId=f979821548c, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=)]
    2016-04-24 忠诚向上

    继续努力

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=176498, encodeId=61fb1e6498b0, content=继续努力,写的很好,如果结合案例病情对年轻医生更有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/fFgUJknhibCy1mxLxGwk0ndVfWXmBh8AOibSFDqsSgnoeicu2QjNDYn0g/0, createdBy=c24f1943525, createdName=覃医生, createdTime=Thu Feb 16 18:21:30 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82144, encodeId=f1fc821445e, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82161, encodeId=36408216109, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82160, encodeId=c53c821604d, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82159, encodeId=e6798215914, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82158, encodeId=306b8215817, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82157, encodeId=113a8215efa, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82156, encodeId=d32d8215668, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82155, encodeId=192282155c5, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82154, encodeId=f979821548c, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=)]
    2016-04-24 忠诚向上

    继续努力

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=176498, encodeId=61fb1e6498b0, content=继续努力,写的很好,如果结合案例病情对年轻医生更有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/fFgUJknhibCy1mxLxGwk0ndVfWXmBh8AOibSFDqsSgnoeicu2QjNDYn0g/0, createdBy=c24f1943525, createdName=覃医生, createdTime=Thu Feb 16 18:21:30 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82144, encodeId=f1fc821445e, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82161, encodeId=36408216109, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82160, encodeId=c53c821604d, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82159, encodeId=e6798215914, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82158, encodeId=306b8215817, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82157, encodeId=113a8215efa, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82156, encodeId=d32d8215668, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82155, encodeId=192282155c5, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82154, encodeId=f979821548c, content=继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 24 07:54:00 CST 2016, time=2016-04-24, status=1, ipAttribution=)]
    2016-04-24 忠诚向上

    继续努力

    0

相关资讯

Chest:院前服用SSRI可增加ICU患者死亡风险

新近的观察性研究发现,服用选择性5-羟色胺再摄取抑制剂(SSRI)患者出现出血、中风等不良反应的危险及死亡率均有增加。但正在服用上述药物对于危重患者预后的影响,目前仍不清楚。 为了明确入院前服用SSRI或5-羟色胺去甲肾上腺素再摄取抑制剂(SNRI),是否与患者的ICU内死亡率相关,来自美国马萨诸塞州剑桥市麻省理工学院的Ghassemi博士等进行了一项研究,提示入院前正在服用SSRI / SNR

值得借鉴的德国ICU病房护理管理

有位医者,赴德国研修护理教育和护理管理,其中,在Dr--Horst--Schmidt医院监护室病房进行6个月的临床研修,在此过程中,对ICU病房的护理管理进一步了解,同时也学到了很多新的知识和技术。深感其高科技的医疗护理水平和科学的管理方法值得我们借鉴,护士优良的工作作风和一流的服务态度,实在令人叹服,给人启示。 ICU病房护理人员配备特点 1.人员配备充足。 床位8张,护士24名,包括护士

JAMA Psychiatry:褪黑素受体激动剂Ramelteon 或可预防ICU和急诊患者谵妄发生(DELIRIA-J研究)

谵妄是综合性医院中最为常见的一种精神障碍,占内科、外科患者的5-15%,特别是在ICU、急诊科、烧伤科、老年科的住院患者中发生率较高,尤其见于老年患者。据统计,急诊入院的老年人中,谵妄发生率为5%-15%,术后更高达50%。 而在ICU病房甚至达到了80%,但识别率仅为17%,在非机械通气患者中,其谵妄发生率为20-50%,机械通气患者发生率高达60-80%。一项用标准化的谵妄症状检查的研究发现

NEJM:探讨重症监护中出血与凝血障碍

凝血障碍的定义为血液凝结成块能力受损的病理状态。但是,对于临床医生来说,该病的定义也包括血栓状态及性质。同时,由于止血途径的多样性,这两种概念同时出现在临床治疗中。一些临床医生认为,如果患者存在轻度凝血异常,那么即使没有出血症状,也可诊断为凝血障碍。本综述旨在阐述上述凝血障碍概念在临床中的意义。此类疾病是重症监护病房(ICU)患者常见病,需要一个合理的临床病理方式来保证准确的诊断及合适的治疗方

Chest:益生菌不能降低ICU或医院死亡率

由于益生菌具有恢复非致病性消化道菌群失调,预防消化道定植致病菌,调节局部和全身免疫功能,降低肠道通透性的特性,因而认为含有益生菌的制剂对危重患者有益。然而,在ICU中使用这些产品的经验十分有限,不同的研究结果甚至是矛盾的。 为此,来自法国法国洛林大学南锡医学院中心医院内科ICU监护室的Barraud D极其同事做了一项研究分析。该研究结果在2013年3月出版的《胸科》(chest)杂志上。结果显

JAMA:ICU的严重脓毒症患者死亡风险下降

脓毒症和感染性休克是大多数重症患者死亡的重要原因。尽管几项随机临床试验显示,严重脓毒症患者的死亡率在过去20年里并没有多大改善,但其在重症监护室(ICU)内的变化趋势仍不清楚。 近日,来自新西兰等国的一项研究显示:澳大利亚和新西兰的严重脓毒症病死率在过去的12年里下降了16.7%。文章在线发表于近期的JAMA上。 澳大利亚和新西兰重症监护学会老年ICU患者数据库收录了澳大利亚和新西兰90%以上